Asarfi Hospital Share Price Today | Stock Price & Asarfi Hospital Share Screener
Track the current Asarfi Hospital share price and stock price live with TickJournal's free stock screener. Track Asarfi Hospital networth to gauge the company's total market size. Use the Asarfi Hospital stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Asarfi Hospital opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Key Statistics and Valuation Ratios
Over the trailing twelve months the company reported revenue of ₹54 and net income of ₹6, with EBITDA of ₹13, an operating margin of 22.0% and a profit margin of 11.1%.
Asarfi Hospital Share Price Chart
Track the current stock price of Asarfi Hospital with an interactive chart. Analyse ASARFI share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Asarfi Hospital stock quote in one place.
Asarfi Hospital Company Profile - Fundamental Screener
Screen Asarfi Hospital company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for ASARFI shares across the equity market and its stock price history, plus the wider market trend.
The company is classified under the Healthcare sector and the Healthcare Services industry, and it trades under ISIN INE0DN001027.
Company Details
Classification
Identifiers and Leadership
Asarfi Hospital Balance Sheet Screener
Screen ASARFI balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.
For 2026, total assets were ₹193, up from ₹164 in 2025.
Latest statistics put total assets at ₹193 and shareholder funds at ₹98, with a leverage ratio of 0.59.
| Item | 2026 | 2025 | 2024 |
|---|---|---|---|
Assets |
|||
| Total Assets | 193 | 164 | 154 |
| Current Assets | 0 | 0 | 0 |
| Fixed Assets | 108 | 102 | 94 |
Liabilities |
|||
| Total Liabilities | 0 | 0 | 0 |
| Current Liabilities | 46 | 42 | 39 |
| Non-Current Liabilities | 0 | 0 | 0 |
Shareholders' Equity |
|||
| Total Equity | 98 | 81 | 70 |
| Share Capital | 20 | 20 | 20 |
| Reserves & Surplus | 78 | 61 | 51 |
Asarfi Hospital Income Statement Screener - Profit & Revenue Analysis
Screen Asarfi Hospital income statement and profit fundamentals. Analyze ASARFI quarterly results. Asarfi Hospital reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.
For 2026-Sept, revenue was ₹54 and net profit was ₹6, equal to earnings per unit of ₹3.10, at an operating margin of 22%.
In that period expenses were ₹41, interest cost ₹1 and tax ₹2. The next period listed, 2026-Jun, shows revenue of ₹48 and net profit of ₹4.
| Item | 2026-Sept | 2026-Jun | 2026-Mar | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun | 2024-Mar | 2023-Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and Expenses | ||||||||||||
| Revenue | 54 | 48 | 46 | 48 | 46 | 37 | 39 | 34 | 32 | 24 | 24 | 21 |
| Expenses | 41 | 38 | 38 | 36 | 36 | 29 | 29 | 26 | 24 | 18 | 20 | 16 |
Operating Costs and Margins | ||||||||||||
| EBITDA | 13 | 10 | 8 | 12 | 10 | 8 | 10 | 8 | 8 | 5 | 4 | 5 |
| Operating Profit % | 22.00% | 20.00% | 17.00% | 22.00% | 20.00% | 20.00% | 18.00% | 21.00% | 22.00% | 21.00% | 16.00% | 20.00% |
| Depreciation | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 4 | 3 |
| Interest | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Profit and Earnings | ||||||||||||
| Profit Before Tax | 8 | 6 | 5 | 7 | 6 | 4 | 5 | 4 | 4 | 2 | -1 | 1 |
| Tax | 2 | 1 | 1 | 2 | 2 | 1 | 2 | 1 | 1 | 0 | -1 | 1 |
| Net Profit | 6 | 4 | 4 | 5 | 4 | 3 | 4 | 3 | 3 | 2 | 0 | 0 |
| EPS | 3.10 | 2.17 | 1.99 | 2.76 | 2.13 | 1.59 | 1.82 | 1.36 | 1.45 | 0.74 | -0.18 | -0.03 |
Asarfi Hospital Cash Flow Screener - Liquidity Fundamentals
Screen ASARFI cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.
In 2026-March, operating activities generated ₹18, and net cash flow was an inflow of ₹5.
Over the same period, investing activities used ₹18 and financing activities provided ₹5.
| Item | 2026-March | 2025-March | 2024-March |
|---|---|---|---|
Cash from Operations and Investing | |||
| Operating Activities | 18 | -4 | 26 |
| Investing Activities | -18 | -7 | -63 |
Financing and Net Cash | |||
| Financing Activities | 5 | 13 | 36 |
| Net Cash Flow | 5 | 1 | -1 |
Asarfi Hospital Shareholding Pattern Screener
See Asarfi Hospital shareholding pattern with promoter, FII, and DII holdings. Check Asarfi Hospital promoter holding and ownership changes for ASARFI on TickJournal, and see how institutional stock price moves affect the market.
In 2026-Mar, promoters held 61.17%, foreign institutions 0.00%, domestic institutions 2.40% and the public 30.63%, spread across 1,316 shareholders.
The shareholder count was 1,316 in 2026-Mar, compared with 1,399 in 2026-Jun.
| Item | 2026-Mar | 2026-Jun | 2026-Sept | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar |
|---|---|---|---|---|---|---|---|---|
Promoter Holding | ||||||||
| Promoter Holding | 61.17% | 61.17% | 61.18% | 61.17% | 61.17% | 61.17% | 61.17% | 61.17% |
Institutional Investors | ||||||||
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.10% | 0.05% | 0.00% | 0.00% |
| DII Holding | 2.40% | 2.97% | 2.84% | 2.92% | 3.18% | 2.19% | 1.98% | 2.33% |
Government, Public and Others | ||||||||
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 30.63% | 30.10% | 30.92% | 30.86% | 29.89% | 30.89% | 31.72% | 31.63% |
| Other Holding | 5.79% | 5.76% | 5.06% | 5.05% | 5.66% | 5.70% | 5.13% | 4.87% |
| Shareholder Count | 1,316 | 1,399 | 1,580 | 1,262 | 1,176 | 1,167 | 1,225 | 1,261 |
Dividend Yield Screener - Share Price & Share Analysis
Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Asarfi Hospital. Asarfi Hospital dividend yield can be compared with peers and other stocks in the market.
Asarfi Hospital Stock Index Membership - Nifty & Sensex
See which indices include Asarfi Hospital stock. Check ASARFI index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.
Complete Index List
Asarfi Hospital Market Events Screener - Corporate Actions
Get Asarfi Hospital corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Asarfi Hospital stock events that may affect ASARFI share price, along with derivatives, futures and options activity and sector gainers.
13 corporate actions are listed, the most recent entry being Quarterly Result Announcement dated November 13, 2026, with a record date of November 13, 2026.
It is followed by Annual General Meeting dated September 18, 2026 and Quarterly Result Announcement dated August 7, 2026.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-11-13 | 2026-11-13 | Quarterly Result Announcement | NA | -2.63% |
| 2026-09-18 | 2026-09-18 | Annual General Meeting | NA | -14.79% |
| 2026-08-07 | 2026-08-07 | Quarterly Result Announcement | NA | -1.15% |
| 2026-05-11 | 2026-05-11 | Quarterly Result Announcement | NA | 17.04% |
| 2026-02-09 | 2026-02-09 | Quarterly Result Announcement | NA | 1.50% |
| 2025-11-10 | 2025-11-10 | Quarterly Result Announcement | NA | 0.00% |
| 2025-09-12 | 2025-09-12 | Annual General Meeting | NA | 16.21% |
| 2025-08-07 | 2025-08-07 | Quarterly Result Announcement | NA | -2.14% |
| 2025-05-08 | 2025-05-08 | Quarterly Result Announcement | NA | 5.12% |
| 2025-01-31 | 2025-01-31 | Quarterly Result Announcement | NA | 1.29% |
| 2024-10-30 | 2024-10-30 | Quarterly Result Announcement | NA | 6.02% |
| 2024-09-13 | 2024-09-13 | Annual General Meeting | NA | 0.43% |
| 2024-01-30 | 2024-01-30 | Extraordinary General Meeting | NA | 13.33% |
Asarfi Hospital Competitors Screener - Peer Stocks Comparison
Screen ASARFI competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.
The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Apollo Hospitals | 125,272 | 53.90 | 25,420 | 15.58% | 2,003 | 61.89 |
| Max Healthcare Institute | 100,339 | 71.20 | 8,536 | 18.82% | 1,442 | 76.17 |
| Manipal Health Enterprises | 92,333 | 104.20 | 10,521 | 25.80% | 917 | 60.80 |
| Aster DM Quality Care | 64,325 | 116.10 | 4,769 | 11.25% | 427 | 57.55 |
| Fortis Healthcare | 60,910 | 57.00 | 9,179 | 16.93% | 1,064 | 57.30 |
| Narayana Hrudayalaya | 38,984 | 45.00 | 7,996 | 43.43% | 811 | 61.49 |
| Global Health | 38,830 | 62.80 | 4,509 | 19.56% | 554 | 64.64 |
| Dr. Lal Path Labs | 33,237 | 57.20 | 2,864 | 12.11% | 510 | 54.28 |
| Krishna Institute of Medical Sciences | 32,269 | 163.00 | 3,931 | 28.16% | 242 | 66.73 |
| Syngene International | 17,533 | 95.70 | 3,809 | 2.56% | 317 | 61.78 |
Asarfi Hospital Company Announcements - News & Reports Screener
Screen ASARFI latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.
20 recent announcements are listed, the latest dated November 17, 2026.
The next most recent announcements are dated November 16, 2026 and November 16, 2026.
| Date | Update | Actions |
|---|---|---|
| 2026-11-17 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-11-16 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-11-16 | Announcement under Regulation 30 (LODR)-Investor Presentation | - |
| 2026-11-16 | Submission Of Unaudited Financial Results For The Quarter And Half Year Ended 30Th September 2026 | - |
| 2026-11-16 | Board Meeting Outcome for Outcome Of Board Meeting Held On 13 November 2026 And Submission Of Unaudited Financial Results For The Quarter And Half Year Ended 30Th September 2026. | - |
| 2026-11-06 | Board Meeting Intimation for To Consider Approve And Take On Record The Unaudited Financial Results Of The Company For The Quarter Ended 30Th September 2026. | - |
| 2026-10-08 | Announcement under Regulation 30 (LODR)-Credit Rating | - |
| 2026-09-27 | Closure of Trading Window | - |
| 2026-09-22 | Shareholder Meeting / Postal Ballot-Scrutinizer"s Report | - |
| 2026-09-18 | Shareholder Meeting / Postal Ballot-Outcome of AGM | - |
| 2026-09-05 | Reg. 34 (1) Annual Report. | - |
| 2026-09-05 | Intimation Of Appointment Of Cost Auditor - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations. 2015. | - |
| 2026-08-25 | Board Meeting Outcome for Outcome Of Board Meeting Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) 2015. | - |
| 2026-08-18 | Board Meeting Intimation for Notice Of 21St Annual General Meeting Of Asarfi Hospital Limited. | - |
| 2026-08-08 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-08-07 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-08-07 | Announcement under Regulation 30 (LODR)-Investor Presentation | - |
| 2026-08-07 | Submission Of Unaudited Standalone And Consolidated Financial Results For The Quarter Ended 30 June 2026 | - |
| 2026-08-07 | Board Meeting Outcome for Submission Of Unaudited Standalone And Consolidated Financial Results For The Quarter Ended 30 June 2026 | - |
| 2026-08-04 | Board Meeting Intimation for The Unaudited Financial Results Of The Company For The Quarter Ended 30Th June 2026. | - |
Frequently Asked Questions
How is the company valued right now?
The P/E ratio is 19.30 and the P/B ratio is 3.53, with earnings per unit of ₹8.47. Market capitalisation stands at ₹354.23 Cr. The company operates in the Healthcare sector, in the Healthcare Services industry, so compare these ratios with its sector peers in the table above.
About This Data
Key statistics were last updated on November 20, 2026. This page covers 3 balance sheet periods, 12 income statement periods, 3 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.